Quanta Inc (fka QNTA)

[falon]

QNTA increased their authorized shares from 100,000,000 to 500,000,000 on November 30, 2020.

QNTA increased their authorized shares from 500,000,000 to 3,000,000,000 on May 28, 2021 and also changed the company’s name, to effect the change of the symbol and give the board of directors the right to effect a reverse split of the stock.

Outstanding Shares 176,458,527 05/22/2021



What Is Capital Stock?

Capital stock is the total amount of stock, both common and preferred, that a public company has the authorization to issue. The difference between common stock and preferred stock is that if a company goes bankrupt, preferred stockholders receive their share of the assets before common stockholders receive theirs (if there's anything left).

Benefits of Increasing Capital Stock

Despite possible dilution of shares, increases in capital stock can ultimately be beneficial for investors. The increase in capital for the company raised by selling additional shares of stock can finance additional company growth. If the company invests the additional capital successfully, then the ultimate gains in stock price and dividend payouts realized by investors may be more than sufficient to compensate for the dilution of their shares.
It is a good sign to investors and analysts if a company can issue a significant amount of additional stock without seeing a significant drop in share price.

QNTA is a company with tremendous potential and has many catalysts waiting to be revealed. The company has positioned itself with the increase in authorized shares to have the ability to raise capital as necessary to finance additional growth.

Just because they have the right to effect a reverse split doesn’t mean it will ever happen. As the company is able to generate more revenue moving forward the selling of shares to finance the company will become less of an issue.

Patience is key as we should see many results from the company’s initiatives come to fruition in the upcoming days, weeks and months.

QNTA closing stock price has fluctuated as low as 0.0398 to a high of 0.1951.

For the quarterly period ended September 30, 2020



NOTE 12 – SUBSEQUENT EVENTS


On November 20, 2020, the Board of Directors approved an increase in the Company’s authorized shares of Common Stock from 100,000,000 to 500,000,000 shares by Unanimous Written Consent in order to provide the Company with sufficient shares to adequately pay down its debt, to allow for compensation to vendors and executives for ongoing services being rendered to the Company, and to accommodate for future financings and acquisitions. On November 20, 2020, the Board Received the Majority Shareholder’s Consent from Phil Sands, holder of 2,500,000 shares of our Series A Preferred Stock, approving the increase in our authorized shares of Common Stock to 500,000,000. No changes to our Preferred Stock are being made. The Secretary of the state of Nevada approved the amendment to the articles of incorporation and approved the share increase.

https://ir.quantrx.com/sec-filings/all-sec-filings?form_type=&year=2020##document-383-0001493152-20-023907-2

SCHEDULE 14C INFORMATION


NOTICE IS HEREBY GIVEN that the following action has been approved pursuant to the written consent of the holders of a majority of the voting power of the outstanding common stock of Quanta Inc., a Nevada corporation (the “Company”, “we”, “us”, or “our”) dated May 28, 2021, in lieu of a special meeting of the stockholders and in accordance with Section 78.315(2) of the Nevada Revised Statutes:

To amend the Company’s Articles of Incorporation, to change the number of authorized shares of common stock of the Company to 3,100,000,000, $0.001 par value consisting of 3,000,000,000 ( Three Billion) and to increase the number of Preferred Shares to 100,000,000 of which 2,500,000 shares are designated as Series A Preferred Stock, 9,000 shares are designated as Series B Preferred Stock, 1,000 are designated as Series C Preferred Stock and the remainder of the Preferred Stock shall have rights, preferences and privileges to be established by the Board of Directors.

To amend the Company’s Articles of Incorporation, to change the name of the Company to Medolife Rx Holdings, Inc.

To effect the change of the symbol of the Company.

To grant the Board of Directors of the Company, for a period of 12 months, the right to effect a reverse stock split with a range between 1 for 10 to 1 for 500 for all outstanding shares of stock

https://ir.quantrx.com/sec-filings/all-sec-filings?form_type=PRE+14C&year=##document-425-0001493152-21-013407-2